DexCom DXCM Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.66B+15.6% | $4.03B+11.3% | $3.62B+24.5% | $2.91B+18.8% | ||
| $1.86B+16.6% | $1.59B+19.6% | $1.33B+29.9% | $1.03B+33.7% | ||
| $2.8B+14.9% | $2.44B+6.5% | $2.29B+21.5% | $1.88B+12.1% | ||
| 60.1%-0.4pp | 60.5%-2.7pp | 63.2%-1.5pp | 64.7%-3.9pp | ||
| $599.1M+8.5% | $552.4M+9.2% | $505.8M+4.5% | $484.2M-6.4% | ||
| $1.29B+0.4% | $1.29B+8.5% | $1.19B+17.6% | $1.01B+24.3% | ||
| $1.89B+2.8% | $1.84B+8.7% | $1.69B+13.4% | $1.49B+5.5% | ||
| $911.8M+52.0% | $600M+0.4% | $597.7M+52.8% | $391.2M+47.2% | ||
| 19.6%+4.7pp | 14.9%-1.6pp | 16.5%+3.1pp | 13.4%+2.6pp | ||
| $176.6M+62.0% | $109M-3.3% | $112.7M+28,275% | -$400K+95.6% | ||
| $1.09B+53.5% | $709M-0.2% | $710.4M+81.8% | $390.8M+52.2% | ||
| $252.1M+89.8% | $132.8M-25.8% | $179M+261% | $49.6M+24.3% | ||
| $836.3M+45.1% | $576.2M+6.4% | $541.5M+58.7% | $341.2M+53.6% | ||
| 17.9%+3.7pp | 14.3%-0.7pp | 14.9%+3.2pp | 11.7%+2.7pp | ||
| $2.09+46.2% | $1.43+10.0% | $1.30+60.5% | $0.81— | ||
| $1.16B+42.3% | $817.7M+4.3% | $783.7M+43.2% | $547.1M+48.7% | ||
| 25%+4.7pp | 20.3%-1.4pp | 21.6%+2.8pp | 18.8%+3.8pp | ||
| $911.8M+52.0% | $600M+0.4% | $597.7M+52.8% | $391.2M+47.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is DexCom's revenue?
- DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.
- Is DexCom profitable?
- DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.
- What are DexCom's profit margins?
- Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.
- What is DexCom's earnings per share?
- DexCom's diluted EPS over the trailing twelve months is $2.33.
- Where does DexCom's income statement data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
